PERNIX THERAPEUTICS HLDGS IN's ticker is PTX and the CUSIP is 71426V108. A total of 105 filers reported holding PERNIX THERAPEUTICS HLDGS IN in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $0 | -100.0% | 551 | -3.7% | 0.00% | – |
| Q1 2016 | $1,000 | 0.0% | 572 | +111.1% | 0.00% | – |
| Q4 2015 | $1,000 | 0.0% | 271 | 0.0% | 0.00% | – |
| Q3 2015 | $1,000 | -50.0% | 271 | +3.4% | 0.00% | – |
| Q2 2015 | $2,000 | 0.0% | 262 | +84.5% | 0.00% | – |
| Q1 2015 | $2,000 | +100.0% | 142 | 0.0% | 0.00% | – |
| Q4 2014 | $1,000 | – | 142 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 1,134,578 | $10,654,000 | 7.22% |
| Consonance Capital Management LP | 3,427,789 | $32,187,000 | 4.15% |
| ACUTA CAPITAL PARTNERS, LLC | 604,075 | $5,672,000 | 3.83% |
| KOPP INVESTMENT ADVISORS LLC | 758,233 | $7,119,000 | 3.42% |
| Aisling Capital LLC | 2,010,000 | $18,874,000 | 2.86% |
| Broadfin Capital, LLC | 6,100,000 | $57,280,000 | 2.49% |
| THOMPSON DAVIS & CO., INC. | 154,760 | $1,453,000 | 1.68% |
| RUDMAN ERROL M | 300,000 | $2,817,000 | 1.14% |
| WALL STREET ASSOCIATES | 1,259,500 | $11,827,000 | 1.13% |
| Timpani Capital Management LLC | 291,377 | $2,736,000 | 1.08% |